Ceftriaxone Sodium/Sulbactam Sodium/Edetic Acid

头孢曲松钠/舒巴坦钠/依地酸

Report date: 2026/04/21 20:00:18

Base Information

Drug NameCeftriaxone Sodium/Sulbactam Sodium/Edetic Acid
Drug Alias NameCeftriaxone Sodium/Sulbactam sodium/EDTA头孢曲松钠•舒巴坦钠•依地酸Ceftriaxone Sodium-Sulbactam Sodium-Edetic Acid头孢曲松钠和舒巴坦钠和依地酸Ceftriaxone Sodium•Sulbactam Sodium•Edetic Acid +[14] 
ClassificationSmall molecules
Mechanisms of ActionBeta Lactamase inhibitorsCell wall inhibitorsBacterial penicillin-binding protein inhibitors
TargetsBeta LactamaseBacterial penicillin-binding protein
Therapy Area/IndicationsGram-Negative Bacterial Infections
Global Approved IndicationsGram-Negative Bacterial Infections
Approved Indications in ChinaN/A
Original Approved Country/TerritoryIndia
Original Approved Date2013/01/01
Country/TerritoryIndia
CombinationsYes Ceftriaxone SodiumEdetic AcidSulbactam sodium
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesVenus Remedies Ltd
China Registration ClassN/A

Develop Information

Active CompaniesVenus Remedies Ltd
Inactive CompaniesN/A
Active IndicationsGram-Negative Bacterial Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01DD63
Related LinksN/A